信必可都保联合无创通气对老年慢性阻塞性肺疾病合并呼吸衰竭患者的影响

The Effect of Symbicortturbuhaler combined with Noninvasive Ventilation on Elderly Patients with Chronic Obstructive Pulmonary Disease complicated with Respiratory Failure

目的探讨信必可都保联合无创通气对老年慢性阻塞性肺疾病合并呼吸衰竭患者的影响。方法回顾性分析我院收治的120例老年慢性阻塞性肺疾病合并呼吸衰竭患者的临床资料。结果对照组60例患者,在常规治疗的基础上,经无创通气治疗,总有效率为71.67%;观察组60例患者,在常规治疗的基础上,采用信必可都保联合无创通气治疗,总有效率为86.67%,与对照组比较,P<0.05,差异具有统计学意义。两组患者治疗前的PaCO2和PaO2指标比较,差异无统计学意义,P>0.05;观察组患者治疗后的PaCO2和PaO2指标均得到明显改善,与对照组比较,P<0.05,差异具有统计学意义。结论信必可都保联合无创通气治疗老年慢性阻塞性肺疾病合并呼吸衰竭患者的临床疗效确切,值得推广应用。

Objective To explore the effect of symbicortturbuhaler combined with non-invasive ventilation on elderly patients with chronic obstructive pulmonary disease complicated with respiratory failure. Methods The clinical data of 120 elderly patients with chronic obstructive pulmonary disease complicated with respiratory failure in our hospital were retrospectively analyzed. Results The total effective rate of 60 patients in the control group was 71.67% after non-invasive ventilation treatment on the basis of routine treatment, while that of 60 patients in the observation group was 86.67% after routine treatment with symbicortturbuhaler combined with non-invasive ventilation treatment. Compared with the control group, the difference was statistically significant (P <0.05). There was no statistically significant difference between PaCO2 and PaO2 before treatment between the two groups, P >0.05;Both PaCO2 and PaO2 were significantly improved after treatment in the observation group. Compared with the control group, P <0.05, the difference is statistically significant. Conclusion Symbicortturbuhaler combined with non-invasive ventilation in the treatment of elderly patients with chronic obstructive pulmonary disease complicated with respiratory failure has a definite clinical effect, which is worthy of popularization and application.